Pursuant to RCW
18.53.010(3) the optometry board adopts the following drug formulary of topically applied drugs for diagnostic and treatment purposes.
(1) Drugs for diagnostic or therapeutic purposes.
(a) Mydriatics.
(b) Cycloplegics.
(c) Miotics.
(d) Anesthetics.
(2) Drugs for therapeutic purposes only.
(a) Anti-infectives.
(b) Antihistamines and decongestants.
(c) Ocular lubricants.
(d) Antiglaucoma and ocular hypotensives.
(e) Anti-inflammatories.
(f) Hyperosmotics.
(g) Other topical drugs approved for ocular use by the FDA.
[Statutory Authority: RCW
18.54.070. WSR 91-06-025 (Order 119B), recodified as § 246-851-410, filed 2/26/91, effective 3/29/91. Statutory Authority: RCW
18.53.010. WSR 89-17-040 (Order PM 853), § 308-53-340, filed 8/11/89, effective 9/11/89.]